Puma Biotechnology Inc (PBYI)
5.015
+0.02
(+0.50%)
USD |
NASDAQ |
Apr 19, 16:00
5.015
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Cash and Short Term Investments (Quarterly): 95.94M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 95.94M |
| September 30, 2023 | 85.03M |
| June 30, 2023 | 74.44M |
| March 31, 2023 | 71.22M |
| December 31, 2022 | 81.07M |
| September 30, 2022 | 77.96M |
| June 30, 2022 | 60.75M |
| March 31, 2022 | 73.91M |
| December 31, 2021 | 82.11M |
| September 30, 2021 | 87.54M |
| June 30, 2021 | 108.98M |
| March 31, 2021 | 109.05M |
| December 31, 2020 | 93.39M |
| September 30, 2020 | 109.02M |
| June 30, 2020 | 107.27M |
| March 31, 2020 | 100.56M |
| December 31, 2019 | 111.64M |
| September 30, 2019 | 110.44M |
| June 30, 2019 | 117.66M |
| March 31, 2019 | 150.40M |
| December 31, 2018 | 165.42M |
| September 30, 2018 | 127.95M |
| June 30, 2018 | 134.51M |
| March 31, 2018 | 78.55M |
| December 31, 2017 | 81.70M |
| Date | Value |
|---|---|
| September 30, 2017 | 106.34M |
| June 30, 2017 | 151.65M |
| March 31, 2017 | 193.98M |
| December 31, 2016 | 229.48M |
| September 30, 2016 | 108.93M |
| June 30, 2016 | 143.79M |
| March 31, 2016 | 181.21M |
| December 31, 2015 | 215.89M |
| September 30, 2015 | 247.78M |
| June 30, 2015 | 282.37M |
| March 31, 2015 | 310.33M |
| December 31, 2014 | 141.33M |
| September 30, 2014 | 153.86M |
| June 30, 2014 | 178.35M |
| March 31, 2014 | 196.11M |
| December 31, 2013 | 83.95M |
| September 30, 2013 | 95.64M |
| June 30, 2013 | 107.52M |
| March 31, 2013 | 118.72M |
| December 31, 2012 | 137.41M |
| September 30, 2012 | 33.35M |
| June 30, 2012 | 41.00M |
| March 31, 2012 | 50.17M |
| December 31, 2011 | 53.38M |
| September 30, 2011 | 0.00 |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
60.75M
Minimum
Jun 2022
117.66M
Maximum
Jun 2019
92.53M
Average
93.39M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| ADMA Biologics Inc | 51.35M |
| Regeneron Pharmaceuticals Inc | 10.84B |
| CytomX Therapeutics Inc | 174.51M |
| Sarepta Therapeutics Inc | 1.676B |
| Mirum Pharmaceuticals Inc | 286.33M |